Research ArticleArticle
Expansion of First-in-class Drug Candidates that Sequester Toxic All-trans-retinal and Prevent Light-induced Retinal Degeneration
Jianye Zhang, Zhiqian Dong, Sreenivasa Mundla, X Eric Hu, William Seibel, Ruben Papoian, Krzysztof Palczewski and Marcin Golczak
Molecular Pharmacology December 23, 2014, mol.114.096560; DOI: https://doi.org/10.1124/mol.114.096560
Jianye Zhang
1 Case Western Reserve University;
Zhiqian Dong
2 Polgenix Inc.;
Sreenivasa Mundla
3 Sreeni Labs Private Limited;
X Eric Hu
4 Aroz Technologies LLC,;
William Seibel
5 College of Medicine, University of Cincinnati
Ruben Papoian
5 College of Medicine, University of Cincinnati
Krzysztof Palczewski
1 Case Western Reserve University;
Marcin Golczak
1 Case Western Reserve University;
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
Research ArticleArticle
Expansion of First-in-class Drug Candidates that Sequester Toxic All-trans-retinal and Prevent Light-induced Retinal Degeneration
Jianye Zhang, Zhiqian Dong, Sreenivasa Mundla, X Eric Hu, William Seibel, Ruben Papoian, Krzysztof Palczewski and Marcin Golczak
Molecular Pharmacology December 23, 2014, mol.114.096560; DOI: https://doi.org/10.1124/mol.114.096560
Research ArticleArticle
Expansion of First-in-class Drug Candidates that Sequester Toxic All-trans-retinal and Prevent Light-induced Retinal Degeneration
Jianye Zhang, Zhiqian Dong, Sreenivasa Mundla, X Eric Hu, William Seibel, Ruben Papoian, Krzysztof Palczewski and Marcin Golczak
Molecular Pharmacology December 23, 2014, mol.114.096560; DOI: https://doi.org/10.1124/mol.114.096560
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement